Mezzettiaside 6

ID: ALA5289837

Chembl Id: CHEMBL5289837

Max Phase: Preclinical

Molecular Formula: C48H78O23

Molecular Weight: 1023.13

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCO[C@@H]1O[C@@H](C)[C@H](OC(=O)CCCCC)[C@@H](O[C@@H]2O[C@@H](C)[C@H](OC(C)=O)[C@@H](O[C@@H]3O[C@@H](C)[C@H](OC(C)=O)[C@@H](O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4OC(C)=O)[C@H]3OC(C)=O)[C@H]2OC(C)=O)[C@H]1O

Standard InChI:  InChI=1S/C48H78O23/c1-12-14-16-17-18-20-22-58-45-35(57)39(36(24(4)60-45)68-32(54)21-19-15-13-2)69-47-43(66-30(10)52)42(38(25(5)61-47)64-28(8)50)71-48-44(67-31(11)53)41(37(26(6)62-48)63-27(7)49)70-46-40(65-29(9)51)34(56)33(55)23(3)59-46/h23-26,33-48,55-57H,12-22H2,1-11H3/t23-,24-,25-,26-,33-,34+,35+,36-,37-,38-,39-,40+,41+,42+,43+,44+,45+,46-,47-,48-/m0/s1

Standard InChI Key:  IOZDPMUCIIZTGL-IEOAANPOSA-N

Alternative Forms

  1. Parent:

    ALA5289837

    ---

Associated Targets(Human)

KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Col2 (437 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1023.13Molecular Weight (Monoisotopic): 1022.4934AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Govindarajan M..  (2018)  Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics.,  143  [PMID:29126728] [10.1016/j.ejmech.2017.10.015]

Source